223 related articles for article (PubMed ID: 32572432)
81. Enteric nervous system.
Grundy D; Schemann M
Curr Opin Gastroenterol; 2007 Mar; 23(2):121-6. PubMed ID: 17268239
[TBL] [Abstract][Full Text] [Related]
82. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
83. Role of vasoactive intestinal peptide and inflammatory mediators in enteric neuronal plasticity.
Ekblad E; Bauer AJ
Neurogastroenterol Motil; 2004 Apr; 16 Suppl 1():123-8. PubMed ID: 15066017
[TBL] [Abstract][Full Text] [Related]
84. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
85. Intestinal microbiota influence the early postnatal development of the enteric nervous system.
Collins J; Borojevic R; Verdu EF; Huizinga JD; Ratcliffe EM
Neurogastroenterol Motil; 2014 Jan; 26(1):98-107. PubMed ID: 24329946
[TBL] [Abstract][Full Text] [Related]
86. The microbiome and immunodeficiencies: Lessons from rare diseases.
Pellicciotta M; Rigoni R; Falcone EL; Holland SM; Villa A; Cassani B
J Autoimmun; 2019 Mar; 98():132-148. PubMed ID: 30704941
[TBL] [Abstract][Full Text] [Related]
87. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
88. Integrative neuroimmunomodulation of gastrointestinal function during enteric parasitism.
Palmer JM; Greenwood-Van Meerveld B
J Parasitol; 2001 Jun; 87(3):483-504. PubMed ID: 11426710
[TBL] [Abstract][Full Text] [Related]
89. A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism.
Grasset E; Puel A; Charpentier J; Collet X; Christensen JE; Tercé F; Burcelin R
Cell Metab; 2017 May; 25(5):1075-1090.e5. PubMed ID: 28467926
[TBL] [Abstract][Full Text] [Related]
90. Tryptophan metabolites get the gut moving.
Benech N; Rolhion N; Sokol H
Cell Host Microbe; 2021 Feb; 29(2):145-147. PubMed ID: 33571438
[TBL] [Abstract][Full Text] [Related]
91. The gut microbiota promotes the pathogenesis of schizophrenia via multiple pathways.
Yuan X; Kang Y; Zhuo C; Huang XF; Song X
Biochem Biophys Res Commun; 2019 Apr; 512(2):373-380. PubMed ID: 30898321
[TBL] [Abstract][Full Text] [Related]
92. The role of enteric neurons in the development and progression of colorectal cancer.
Rademakers G; Vaes N; Schonkeren S; Koch A; Sharkey KA; Melotte V
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):420-434. PubMed ID: 28847715
[TBL] [Abstract][Full Text] [Related]
93. New insights into human enteric neuropathies.
De Giorgio R; Guerrini S; Barbara G; Cremon C; Stanghellini V; Corinaldesi R
Neurogastroenterol Motil; 2004 Apr; 16 Suppl 1():143-7. PubMed ID: 15066021
[TBL] [Abstract][Full Text] [Related]
94. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life.
Takiishi T; Fenero CIM; Câmara NOS
Tissue Barriers; 2017 Oct; 5(4):e1373208. PubMed ID: 28956703
[TBL] [Abstract][Full Text] [Related]
95. Potential roles of enteric glia in bridging neuroimmune communication in the gut.
Chow AK; Gulbransen BD
Am J Physiol Gastrointest Liver Physiol; 2017 Feb; 312(2):G145-G152. PubMed ID: 28039160
[TBL] [Abstract][Full Text] [Related]
96. Microbiota modulate ENS maturation.
Dickson I
Nat Rev Gastroenterol Hepatol; 2018 Aug; 15(8):454-455. PubMed ID: 29934558
[No Abstract] [Full Text] [Related]
97. Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.
Aguilera M; Cerdà-Cuéllar M; Martínez V
Gut Microbes; 2015; 6(1):10-23. PubMed ID: 25531553
[TBL] [Abstract][Full Text] [Related]
98. Gastrointestinal Neuropathies: New Insights and Emerging Therapies.
Pesce M; Borrelli O; Saliakellis E; Thapar N
Gastroenterol Clin North Am; 2018 Dec; 47(4):877-894. PubMed ID: 30337038
[TBL] [Abstract][Full Text] [Related]
99. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J
J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073
[TBL] [Abstract][Full Text] [Related]
100. GI infections are associated with an increased risk of Parkinson's disease.
Nerius M; Doblhammer G; Tamgüney G
Gut; 2020 Jun; 69(6):1154-1156. PubMed ID: 31201287
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
